SCHEMBL28596171

SCHEMBL28596171

CCOC(=O)CC1=CC(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
EPHX2 P34913 1/20 0.35
KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9621965 0.72 NFKB1 (0.44) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL4910405 0.72 NFKB1 (0.44) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL18530382 0.70 KMT2A (0.43) KMT2AALDH1A1MEN1L3MBTL1SMN1; SMN2
SCHEMBL4417994 0.69 NFKB1 (0.47) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL4426330 0.69 NFKB1 (0.47) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL15471700 0.69 NFKB1 (0.44) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL15471468 0.69 NFKB1 (0.50) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL15424788 0.69 NFKB1 (0.50) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL15424787 0.69 NFKB1 (0.44) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL1928948 0.69 NFKB1 (0.56) NFKB1NFKB2RELAKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112778325-A ACC inhibitor and application thereof 南京瑞捷医药科技有限公司 2021-05-11 CN disclosed